Nurix Therapeutics Announces Initiation of Phase 1b Expansion Cohorts in Ongoing Phase 1 Trial of NX-2127

Thursday, May 26, 2022 1 min read

Key Takeaway: Nurix Therapeutics Announces Initiation of Phase 1b Expansion Cohorts in Ongoing Phase 1 Trial of NX-2127

Full Press Release Details

Nurix Therapeutics Announces Initiation of Phase 1b Expansion Cohorts in Ongoing Phase 1 Trial of NX-2127.